- Home
- LAKE vs ENTA Comparison
LAKE vs ENTA Comparison
Compare LAKE & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAKE
- ENTA
- Stock Information
- Founded
- LAKE 1982
- ENTA 1995
- Country
- LAKE United States
- ENTA United States
- Employees
- LAKE N/A
- ENTA N/A
- Industry
- LAKE Industrial Specialties
- ENTA Biotechnology: Pharmaceutical Preparations
- Sector
- LAKE Health Care
- ENTA Health Care
- Exchange
- LAKE Nasdaq
- ENTA Nasdaq
- Market Cap
- LAKE 192.4M
- ENTA 154.0M
- IPO Year
- LAKE 1986
- ENTA 2013
- Fundamental
- Price
- LAKE $15.48
- ENTA $5.23
- Analyst Decision
- LAKE Strong Buy
- ENTA Buy
- Analyst Count
- LAKE 3
- ENTA 4
- Target Price
- LAKE $26.00
- ENTA $17.25
- AVG Volume (30 Days)
- LAKE 95.0K
- ENTA 255.5K
- Earning Date
- LAKE 04-09-2025
- ENTA 05-05-2025
- Dividend Yield
- LAKE 0.78%
- ENTA N/A
- EPS Growth
- LAKE N/A
- ENTA N/A
- EPS
- LAKE N/A
- ENTA N/A
- Revenue
- LAKE $167,211,000.00
- ENTA $66,590,999.00
- Revenue This Year
- LAKE $26.83
- ENTA N/A
- Revenue Next Year
- LAKE $4.32
- ENTA N/A
- P/E Ratio
- LAKE N/A
- ENTA N/A
- Revenue Growth
- LAKE 34.10
- ENTA N/A
- 52 Week Low
- LAKE $14.58
- ENTA $4.09
- 52 Week High
- LAKE $27.28
- ENTA $17.24
- Technical
- Relative Strength Index (RSI)
- LAKE 33.34
- ENTA 46.08
- Support Level
- LAKE $15.38
- ENTA $4.55
- Resistance Level
- LAKE $16.56
- ENTA $5.29
- Average True Range (ATR)
- LAKE 1.52
- ENTA 0.46
- MACD
- LAKE -0.15
- ENTA 0.08
- Stochastic Oscillator
- LAKE 14.40
- ENTA 72.20
About LAKE Lakeland Industries Inc.
Lakeland Industries Inc manufactures and sells safety garments and accessories for the industrial protective clothing market. Its product segments include Disposables, Chemicals, Fire, Gloves, High Visibility, High-Performance Wear, and Wovens. Its customers include integrated oil, chemical/petrochemical, utilities, automobile, steel, glass, construction, smelting, munition plants, janitorial, pharmaceutical, and mortuaries, as well as scientific and medical laboratories. Its geographical segments include the United States, Latin America, Canada, Asia, Mexico, Europe (United Kingdom), and Other Foreign.
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.